Clinical trial
A Randomized, Double-Blind, Bilateral Comparison Study of the Safety and Efficacy of 10XB-101 in Adult Subjects With Bilateral Flank Adiposity
NCT05760248 is registered in ClinicalTrials.gov with 10xBio, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Bilateral Comparison Study of the Safety and Efficacy of 10XB-101 in Adult Subjects With Bilateral Flank Adiposity
- Lead sponsor
- 10xBio, LLC
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 4, 2023
- Completion date
- January 22, 2025
- Enrollment
- 13 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
subcutaneous fat disorder